home / stock / cvrx / cvrx news


CVRX News and Press, CVRx Inc. From 11/05/25

Stock Information

Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com

Menu

CVRX CVRX Quote CVRX Short CVRX News CVRX Articles CVRX Message Board
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...

CVRX - CVRx GAAP EPS of -$0.49 beats by $0.01, revenue of $14.7M beats by $0.54M

2025-11-05 17:00:45 ET More on CVRx Seeking Alpha’s Quant Rating on CVRx Historical earnings data for CVRx Financial information for CVRx Read the full article on Seeking Alpha For further details see: CVRx GAAP EPS of -$0.49 beats by $0.01...

CVRX - CVRx Reports Third Quarter 2025 Financial and Operating Results

MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and o...

CVRX - Expected US Company Earnings on Wednesday, November 5th, 2025

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

CVRX - CVRx to Present at the Jefferies Global Healthcare Conference in London

MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management...

CVRX - CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to re...

CVRX - CVRx outlines $55M-$57M revenue target for 2025 as sales force transition nears completion

2025-08-04 19:27:52 ET More on CVRx CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript CVRx: Sell-Off Ignores Its True Potential CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript CVRx GAAP EPS of -$0.57 misses by $0.05, revenue of $13.6M beats by ...

CVRX - CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

2025-08-04 19:27:18 ET Call Start: 16:30 Call End: 17:09 CVRx, Inc. (CVRX) Q2 2025 Earnings Conference Call August 04, 2025, 04:30 PM ET Company Participants Jared Oasheim - Chief Financial Officer Kevin Hykes - President, CEO & Director Conference ...

CVRX - CVRx GAAP EPS of -$0.57 misses by $0.05, revenue of $13.6M beats by $0.38M

2025-08-04 17:41:39 ET More on CVRx CVRx: Sell-Off Ignores Its True Potential CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript CVRx shares rise on Medicare proposal for Barostim implant procedure CVRx downgraded at J.P. Morgan after Q1 sales miss...

CVRX - CVRx Reports Second Quarter 2025 Financial and Operating Results

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and o...

CVRX - Expected US Company Earnings on Monday, August 4th, 2025

Kyndryl Holdings Inc. (KD) is expected to report $0.25 for Q1 2026 Bruker Corporation (BRKR) is expected to report $0.33 for Q2 2025 Vornado Realty Trust (VNO) is expected to report $0.53 for Q2 2025 Diamondback Energy Inc. (FANG) is expected to report $2.63 for Q2 2025 Freightcar...

Previous 10 Next 10